Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Arterra Bioscience SpA ( (IT:ARBS) ) has provided an update.
Arterra Bioscience S.p.A. has convened its ordinary shareholders’ meeting for 29 April 2026, with a possible second call on 30 April 2026 at its Naples headquarters, to approve the 2025 financial statements, decide on profit allocation and dividend distribution, and confirm or appoint a statutory auditor for the 2026–2028 term. The company detailed procedures for participation, including video-conference access, proxy voting, and shareholder rights to supplement the agenda and submit questions, and confirmed that all related meeting documentation will be made available within legal deadlines on its website and through Borsa Italiana, providing transparency and facilitating investor engagement.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is a green biotechnology company focused on research and development in the biotech sector, and has been listed since 2019 on the Euronext Growth Milan market of Borsa Italiana. The company has a share capital of €332,924.65, represented by 6,658,493 ordinary shares, and holds 144,800 treasury shares as of the notice date.
Average Trading Volume: 19,563
Technical Sentiment Signal: Strong Buy
Current Market Cap: €20.31M
See more data about ARBS stock on TipRanks’ Stock Analysis page.